Control Bionics Limited announced the appointment of Jeremy Steele as a member of the board, effective from 19 January 2023. Mr. Steele brings over 25 years of global corporate experience across a wide range of industries including healthcare, software, financial services and retail in senior roles, including most recently as Executive Chairman and subsequently CEO of CardioScan. Mr. Steele will initially be based in his current location of Singapore, in the midst of key Australasian markets and may transition to the CBL office in Melbourne over time.

Upon the appointment of Mr. Steele, Rob Wong will resign as a director. The Board would like to acknowledge the contribution of Mr. Wong who led the company since January 2017, until his recent resignation due to an ongoing medical condition.